122 related articles for article (PubMed ID: 4187540)
1. Long-acting thyroid stimulator in euthyroid relatives of thyrotoxic patients.
Wall JR; Good BF; Hetzel BS
Lancet; 1969 Nov; 2(7629):1024-6. PubMed ID: 4187540
[No Abstract] [Full Text] [Related]
2. Positive correlation of the long-acting thyroid stimulator (LATS) with the percentage of endogenously labelled 131 I triiodothyronine in the plasma of hyperthyroid patients.
Emrich D; Albani M; zur Mühlen A von
Acta Endocrinol (Copenh); 1971 Nov; 68(3):445-50. PubMed ID: 4107957
[No Abstract] [Full Text] [Related]
3. [Cytogenetic studies in patients with thyroiditis and LATS and antibody-positive hyperthyroidism].
Tolksdorf M; Schemmel K; Mühlenstedt D; Uthgenannt H; Müller W
Schweiz Med Wochenschr; 1969 Jul; 99(30):1082-5. PubMed ID: 5351142
[No Abstract] [Full Text] [Related]
4. [Evolution of immunoglobulins IgA, IgM, IgG and LATS during treatment of hyperthyroidism with carmibazole and radioiodine].
Mahaux JE; Delcourt R; Nagel M; Chamla-Soumenkoff J; Levin S
Ann Endocrinol (Paris); 1970; 31(2):314-23. PubMed ID: 4192759
[No Abstract] [Full Text] [Related]
5. Studies on the antigen reacting with the thyroid-stimulating immunoglobulin (LATS) in thyrotoxicosis.
Benhamou-Glynn N; el-Kabir DJ; Roitt IM; Doniach D
Immunology; 1969 Feb; 16(2):187-204. PubMed ID: 4181510
[TBL] [Abstract][Full Text] [Related]
6. Hypothyroidism after treatment with sodium iodide I-131. Incidence and relationship to antithyroid antibodies, long-acting thyroid stimulator (LATS), and infiltrative ophthalmopathy.
Burke G; Silverstein GE
JAMA; 1969 Nov; 210(6):1051-8. PubMed ID: 4900342
[No Abstract] [Full Text] [Related]
7. Long-acting thyroid stimulator in thyrotoxic monozygous twins.
Priest WM
Br Med J; 1970 Jul; 3(5716):205. PubMed ID: 5311030
[No Abstract] [Full Text] [Related]
8. Hyperthyroidism and demonstration of circulating long-acting thyroid stimulator following hypophysectomy for chromophobe adenoma.
Burke G
J Clin Endocrinol Metab; 1967 Aug; 27(8):1161-6. PubMed ID: 4166582
[No Abstract] [Full Text] [Related]
9. An analysis of gastric parietal cell antibodies and thyroid cell antibodies in patients with pernicious anaemia and thyroid disorders.
Cruchaud A; Juditz E
Clin Exp Immunol; 1968 Oct; 3(8):771-81. PubMed ID: 4180858
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.
Bonnyns M; Vanhaelst L
J Endocrinol; 1969 Jan; 43(1):125-6. PubMed ID: 4886576
[No Abstract] [Full Text] [Related]
11. Studies on the nature of plasma thyroid stimulating activity in hyperthyroidism.
Hoffman MJ; Mason EK; Good BF; Hetzel BS; Ferguson K
Australas Ann Med; 1967 May; 16(2):98-106. PubMed ID: 4167406
[No Abstract] [Full Text] [Related]
12. Immunoglobulin levels and long-acting thyroid stimulator (LATS) in hyperthyroidism. A preliminary study.
Yamakido M; Yokoyama M; Noguchi S
Hawaii Med J; 1969; 29(2):118-9. PubMed ID: 5361480
[No Abstract] [Full Text] [Related]
13. [Incidence of L.A.T.S. demonstration in untreated recent hyperthyroidism. Comparison of 2 continuous series].
Mornex R; Massin JP; Orgiazzi J; Savoie JC
Ann Endocrinol (Paris); 1972; 33(2):177-84. PubMed ID: 4678455
[No Abstract] [Full Text] [Related]
14. The effect of triiodothyronine on cervical lymphoid structures, thyroid activity, IgG and IgM immunoglobulin level and exophthalmos in Graves' disease.
Mahaux JE; Chamla-Soumenkoff J; Delcourt R; Nagel N; Levin S
Acta Endocrinol (Copenh); 1969 Jul; 61(3):400-6. PubMed ID: 4184992
[No Abstract] [Full Text] [Related]
15. [Characterization of the long-acting thyroid stimulator. Considerations on preliminary results].
Tourneur R; Letonturier P; Sénécal P
MMW Munch Med Wochenschr; 1974 Mar; 116(13):677-9. PubMed ID: 4212576
[No Abstract] [Full Text] [Related]
16. [Isolation of long acting thyroid stimulator (LATS) and thyroid stimulating hormone (TSH) in the serum].
Ochi Y; Shiomi K; Yatani T; Yoshimura M; Miyazaki T
Horumon To Rinsho; 1973 Jan; 21(1):49-52. PubMed ID: 4736415
[No Abstract] [Full Text] [Related]
17. [Clinical studies of long-acting thyroid stimulator].
Eguchi Y
Nihon Naibunpi Gakkai Zasshi; 1970 Nov; 46(8):939-52. PubMed ID: 4099204
[No Abstract] [Full Text] [Related]
18. Qualitative and quantitative abnormalities of immunoglobulins in relatives of patients with idiopathic paraprotenemia. A study of 12 families.
Petite J; Cruchaud A
Helv Med Acta; 1970 Oct; 35(4):248-65. PubMed ID: 4097006
[No Abstract] [Full Text] [Related]
19. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
[No Abstract] [Full Text] [Related]
20. The interaction between thyroid tissue and the long-acting thyroid stimulator.
Kendall-Taylor P; Smith BR; Munro DS
Q J Med; 1971 Oct; 40(160):564-5. PubMed ID: 4110160
[No Abstract] [Full Text] [Related]
[Next] [New Search]
